Tsubaki Journal
Pharma & Frontier Medicine Journal
Where to start
Regulation & SafetyPharma NewsTracking drug regulation, pharmacy compliance, recalls and safety across Japan, the US, UK, Australia and Europe.View all 9→
Advanced Medicine JapanJapan Frontier TechnologyJapanese hospitals, BNCT, proton/heavy-ion therapy, precision diagnosis, university-hospital collaboration and cross-border care.View all 12→
Regenerative MedicineRegenerative MedicineCovering iPS, cell therapy, cardiovascular, diabetes, ophthalmology, and Japan's regenerative-medicine system and clinical trials.View all 5→
Global Pharmacy ModelsGlobal Pharmacy WatchBreaking down international pharmacy models: Amazon Pharmacy, Walgreens, Boots, Pharmacy2U, Chemist Warehouse and more.View all 5→
Safe Medicine GuideSafe Use & Buying GuidesExplaining Japan's OTC drugs, Class-1 medicines, pharmacist checks, prescription inquiries and cross-border purchasing risks.View all 7→Browse all articles
28 articles
How Japan Revises a Package Insert: The Instruction Notices Behind It
How to Read Japan’s Drug Recalls and Safety Alerts: PMDA Recall Information, Yellow/Blue Letters, and a User Action Checklist
What Japan’s 2025 Mystery-Shopper Survey Found About Medicine Sales Rules
How to Judge Whether an Online Pharmacy Is Trustworthy: The Four Red Lines of Prescriptions, Licenses, Pharmacists, and Price
The Online Purchase Process for Class-1 OTC Medicines: Why You Cannot Order Directly, and What the Pharmacist’s Confirmation Should Ask
2026 Update to Japan’s Medicine Sales System: Online Medication Guidance, Abuse Prevention, and the Boundaries of Online Sales
Advanced Medical Care in Japan: What Type A and Type B Actually Mean
Japan’s First Dual-Use CGRP Drug Arrives: What Pfizer’s Nurtec Launch Means for Migraine Care
Carbon Ion Radiotherapy Under Japan’s Advanced Medical Care System
What “FDA Approved” Does and Does Not Mean for Japan
Regenerative Medicine Clinical-Trial Glossary: jRCT, Phase I/II, Eligibility, Endpoints, and Conditional Approval
International Pharmacy Case Study: How the Boots Health Hub Connects Pharmacy, Online Doctor, and Health Content
A Symptom-Based Guide to Common OTC Medicines: Colds, Pain Relief, Rhinitis, Gastrointestinal, and Eye Care
Japan’s Regenerative Medicine Enters the Stage of Clinical Implementation: iPS Approvals, Conditional and Time-Limited Approval, and the Boundaries of Patient Expectations
An Introduction to Japan’s Advanced Radiotherapies: What BNCT, Proton Beam, and Heavy-Ion (Carbon-Ion) Therapy Are Each Suited For
Observing International Online Pharmacies: How Prescription Management Is Being Reshaped, from Amazon Pharmacy to Pharmacy2U
First Catheter-Delivered iPS Cardiomyocyte Spheroid Case Completed: How Heartseed’s HS-005 Advances Minimally Invasive Regenerative Care for Heart Failure
Tokushima University TUFF-IPC: What the First Case of Autologous Adipose-Derived Regenerated Beta-Cell Transplantation for Type 1 Diabetes Means
A BNCT Thoracic-Tumor Basket Trial Is Underway in Japan: Why Patients with Recurrent Lung, Esophageal, or Breast Cancer Are Paying Attention
MOU Between Southern Tohoku Hospital and Shanghai Jiahui International Hospital: A New Channel for BNCT, Proton Therapy, and China-Japan Oncology Collaboration
Nippon Medical School Hospital: A Century-Old Comprehensive Medical System from Emergency Care and Cancer Treatment to Precision Prevention
Japan Pharma Briefs: Otsuka’s ADHD Drug Clears the US, Pfizer and Eisai Team Up on Migraine Treatment
Inside the 2026 Global Pharma Rankings: Roche Holds the Top Spot as Lilly’s GLP-1 Franchise Surges
Parkinson’s iPS-Cell Therapy Enters Japan’s Public Insurance: the ¥55.3 Million “Amchepry”
In Memoriam: Susumu Tonegawa (1939–2026) and Japan’s Nobel Legacy in Medicine
What Is Kampo? A Guide to Japanese Herbal Medicine for Global Buyers
Importing Japanese Pharmaceuticals and Health Products: A Regulatory Overview for Buyers
Japan’s Pharmaceutical Industry: Leading Manufacturers and Innovation
No articles match your filter.
Journal content is for information only and does not constitute diagnosis, treatment, medication or medical-travel advice.